Last 26,150 KRW
Change Today -600.00 / -2.24%
Volume 259.6K
007570 On Other Exchanges
Korea SE
Korea SE
As of 2:22 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

ilyang pharmaceutical co ltd (007570) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/16/14 - 31,500
52 Week Low
08/13/14 - 22,450
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ILYANG PHARMACEUTICAL CO LTD (007570)

Related News

No related news articles were found.

ilyang pharmaceutical co ltd (007570) Related Businessweek News

No Related Businessweek News Found

ilyang pharmaceutical co ltd (007570) Details

Ilyang Pharamaceutical Co., Ltd. engages in the development and supply of pharmaceutical products primarily in Korea. The company offers nutrition supplements; drink products; ETC products; OEM products; and OTC products. It is also involved in the research and development of IY-GV50205 anti-cancer drug; IY-81149, a proton pump inhibitor, which is in multinational phase II b studies for the treatment of ulcers; Immunan for the treatment of anti-cancer chemotherapy side effects, and anti-cancer effects of antineo plastic drugs; testosterone that can be applied to fatigue, hypodynamia, melancholia, impotence, and anaphrodisia by congenital, adventitious, and senescent factors; lactobacillus, which is in clinical trials for constipation and diarrhea; and human growth hormones. The company also exports its products primarily to the United States and Europe. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharamaceutical Co., Ltd. in May 1991. Ilyang Pharamaceutical Co., Ltd. was founded in 1946 and is headquartered in Yongin, South Korea.

588 Employees
Last Reported Date: 11/14/13
Founded in 1946

ilyang pharmaceutical co ltd (007570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ilyang pharmaceutical co ltd (007570) Key Developments

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 30, 2014

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 30, 2014., at 09:00 Korea Standard Time. Location: Headquarters Auditorium. Agenda: To consider audit reports, sales reports; to consider 43rd financial statements (including the statement of retained earnings) ended March 31, 2014; to consider the election of directors; to consider appointment of audit committee; and to consider the approval of director remuneration.

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 31, 2013

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 31, 2013., at 09:00 Tokyo Standard Time.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
007570:KS 26,150.00 KRW -600.00

007570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 007570.
View Industry Companies

Industry Analysis


Industry Average

Valuation 007570 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILYANG PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at